Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 05, 2021

SELL
$5.36 - $7.99 $482 - $719
-90 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$5.82 - $8.72 $523 - $784
90 New
90 $1,000
Q1 2021

May 24, 2021

SELL
$7.2 - $16.82 $648 - $1,513
-90 Closed
0 $0
Q4 2020

Feb 09, 2021

SELL
$5.77 - $11.33 $2,885 - $5,665
-500 Reduced 84.75%
90 $1,000
Q3 2020

Nov 16, 2020

BUY
$5.09 - $11.07 $3,003 - $6,531
590 New
590 $7,000

Others Institutions Holding KLDO

About Kaleido Biosciences, Inc.


  • Ticker KLDO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,622,600
  • Description
  • Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...
More about KLDO
Track This Portfolio

Track Advisory Services Network, LLC Portfolio

Follow Advisory Services Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Services Network, LLC with notifications on news.